These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38607324)

  • 1. Cell-Mediated Immune Response Against
    Khanna H; Gupta S; Sheikh Y
    J Interferon Cytokine Res; 2024 Jun; 44(6):244-259. PubMed ID: 38607324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated immunity against tuberculosis: implications for vaccine development.
    Achkar JM; Casadevall A
    Cell Host Microbe; 2013 Mar; 13(3):250-62. PubMed ID: 23498951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies and tuberculosis.
    Jacobs AJ; Mongkolsapaya J; Screaton GR; McShane H; Wilkinson RJ
    Tuberculosis (Edinb); 2016 Dec; 101():102-113. PubMed ID: 27865379
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ryndak MB; Laal S
    Front Cell Infect Microbiol; 2019; 9():299. PubMed ID: 31497538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
    Tameris M; Geldenhuys H; Luabeya AK; Smit E; Hughes JE; Vermaak S; Hanekom WA; Hatherill M; Mahomed H; McShane H; Scriba TJ
    PLoS One; 2014; 9(2):e87340. PubMed ID: 24498312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against
    Chen Y; Xiao JN; Li Y; Xiao YJ; Xiong YQ; Liu Y; Wang SJ; Ji P; Zhao GP; Shen H; Lu SH; Fan XY; Wang Y
    Front Immunol; 2018; 9():3190. PubMed ID: 30700988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.
    Achkar JM; Prados-Rosales R
    Curr Opin Immunol; 2018 Aug; 53():30-37. PubMed ID: 29656063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.
    Ernst JD
    Cell Host Microbe; 2018 Jul; 24(1):34-42. PubMed ID: 30001523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cells and antibodies in the defense against Mycobacterium tuberculosis infection.
    Achkar JM; Chan J; Casadevall A
    Immunol Rev; 2015 Mar; 264(1):167-81. PubMed ID: 25703559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 cytokines, true functional signatures for protective immunity against TB?
    Zeng G; Zhang G; Chen X
    Cell Mol Immunol; 2018 Mar; 15(3):206-215. PubMed ID: 29151578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and Chemokines in Mycobacterium tuberculosis Infection.
    Domingo-Gonzalez R; Prince O; Cooper A; Khader SA
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity.
    Ma J; Tian M; Fan X; Yu Q; Jing Y; Wang W; Li L; Zhou Z
    Oncotarget; 2016 Sep; 7(39):63804-63815. PubMed ID: 27566581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering protective immunity against tuberculosis: implications for vaccine development.
    Counoupas C; Triccas JA; Britton WJ
    Expert Rev Vaccines; 2019 Apr; 18(4):353-364. PubMed ID: 30793629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection.
    Lin MY; Ottenhoff TH
    Biol Chem; 2008 May; 389(5):497-511. PubMed ID: 18953716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.
    Urdahl KB
    Semin Immunol; 2014 Dec; 26(6):578-87. PubMed ID: 25453230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.
    Cooper AM; Khader SA
    Immunol Rev; 2008 Dec; 226():191-204. PubMed ID: 19161425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.